Clostridium difficile infection in patients with haematological malignant disease: Risk factors, faecal toxins and pathogenic strains

Epidemiology and Infection

Volumn 100, Issue 1, 1988, Pages 63-72

  Heard, S R ^a   Wren, B ^a   Barnett, M J ^a   Thomas, J M ^a   Tabaqchali, S ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TOXIN;

ACUTE LEUKEMIA; CLOSTRIDIUM DIFFICILE; COMPLICATION; ETIOLOGY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENICITY; RISK FACTOR; SHORT SURVEY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TOXINS; CLOSTRIDIUM; CROSS INFECTION; DISEASE OUTBREAKS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; FEMALE; HEMATOLOGIC DISEASES; HUMAN; LEUKEMIA; MALE; MIDDLE AGE; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0023873753     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268800065560     Document Type: Article

References (24)

1. Barclay F. & Borriello S. P. (1981). Clostridium difficile and colonization resistance. In Antibiotic-associated-diarrhoea and Colitis (ed. Borriello S. P.), pp. 80–87. The Hague: Martinus Nijhoff.
2. Bartlett J. G. & Taylor N. S. (1984). Antibiotic associated colitis. In Medical Microbiology, vol. I (ed. Easmon C. S. F., Jelkjaszewicz J., Brown M. R. W. and Lambert P. A.), pp. 1–48. London: Academic Press.
3. Burdon D. W., George R. H., Mogg G. A. G., Aram Y., Johnson M., Alexander Williams J. & Keighley M. R. B. (1981). Faecal toxin and severity of antibiotic-associated pseudomembranous colitis. Journal of Clinical Pathology 32, 548–551. 10.1136/jcp.34.5.548
4. Delmee M., Homel M. & Wauters G. (1985). Serogrouping of Clostridhnn difficile strains by slide agglutination. Journal of Clinical Microbiology 21, 323–327. 3980688
5. Fainstein V., Bodey G. P. & Fekety R. (1981). Relapsing pseudomembranous colitis associated with cancer chemotherapy. Journal of Infectious Diseases 143, 865. 6166695
6. George R. H., Symond J. M., Dinnock F., Brown J. D., Arabi Y., Shinagawa N., Keighley M., Alexander-Williams J. & Burdon J. D. W. (1978). Identification of Clostridium difficile as a cause of pseudomembranous colitis. British Medical Journal i, 695. 10.1136/bmj.1.6114.695
7. George W. L., Sutter V. L., Citron D. & Finegold S. M. (1979). Selective and differential medium for isolation of Clostridium difficile. Journal of Clinical Microbiology 9, 214–219. 429542
8. Heard S. R., O'Farrell S., Holland D., Crook S., Barnett M. J. & Tabaqchali S. (1986). The epidemiology of Clostridium difficile with use of a typing scheme: nosocomial acquisition and cross-infection among immunocompromised patients. Journal of Infectious Diseases 1, 159–162.
9. Holeman L. V., Cato E. P. & Moore W. E. C. (eds) (1977). Anaerobe Laboratory Manual, 4th edn, p. 98. Virginia Polytechnic Institute and State University, Blacksburg, Virginia.
10. Keighley B. R. B., Burdon D. W., Aram Y., Alexander-Williams J., Thompson H., Youngs D., Johnson M., Bentley S. L., George R. H. & Mogg G. A. G. (1978). Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. British Medical Journal ii, 1667–1669. 10.1136/bmj.2.6153.1667
11. Kim K. H., Fekety R., Batis D. H., Brown D., Cudmore M., Silva J. & Water D. (1981). Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. Journal of Infectious Diseases 1, 42–50.
12. Malamou-Ladas H., O'Farrell S., Nash J. Q. & Tabaqchali S. (1983). Isolation of Clostridium difficile from patients and the environment of hospital wards. Journal of Clinical Pathology 36, 88–92. 10.1136/jcp.36.1.88 6822682
13. Morris J. G., Jarvis W. R., Nuvey-Montiel O. L., Towns M. L., Thompson P. S., Dowell V. R., Hill E. O., Vogler W. R., Winton E. F. & Hughes J. M. (1984). Clostridmm difficile: colonization and toxin production in a cohort of patients with malignant haematological disorders. Archives of Internal Medicine 144, 967–969. 10.1001/archinte.144.5.967 6370168
14. Ramplino A., Warren R. E., Bevan C. E., Hoggarth C. E., Swirsky D. & Hayhoe F. G. J. (1985). Clostridium difficile in haematological malignancy. Journal of Clinical Pathology 38, 445–451. 10.1136/jcp.38.4.445 3857233
15. Redmond S. C., Ketley J. M., Mitchell T. J., Stephens J., Burdon D. W. & Candy D. C. A. (1985). Detection of Clostridium difficile enterotoxin (toxin A) by ELJSA and other techniques. In Isolation and Identification of Microorganisms of Medical and Veterinary Importance (ed. Collins C. H. and Grange J. M.), Society for Applied Bacteriology Technical Series 21, pp. 237–249. London: Academic Press.
16. Rogers T. R., Petkou M., Lucas C., Chung J. T. N. & Barrett A. J. (1981). Spread of Clostridium difficile among patients receiving non-absorbable antibiotics for gut decontamination. British Medical Journal 283, 408–409. 10.1136/bmj.283.6288.408-a 6789988
17. Slavin R. E., Dias M. B. & Soral R. (1978). Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols. A clinicopathologic study of 33 patients. Cancer 42, 1747–1759. 10.1002/1097-0142(197810)42:4<1747::AID-CNCR2820420413>3.0.CO;2-T 709532
18. Stephens J., Wilkins T., Krivan H., Stiles B., Carmen R. & Lyerly D. (1985). Clostridial toxins active locally in the gastrointestinal tract. In Microbial Toxins and Diarrhoeal Disease (Ciba Foundation Symposium), pp. 230–241. London: Pitman.
19. Tabaqchali S., O'Farrell S., Holland D. & Silman R. (1984). Typing scheme for Clostridium difficile: its application in clinical and epidemiological studies. Lancet i, 935–938. 10.1016/S0140-6736(84)92392-4
20. Tabaqchali S., O'Farrell S., Holland D. & Silman R. (1986). Method for typing of Clostridium difficile based on PAGE of 35S-Methionine-labelled proteins. Journal of Clinical Microbiology 23, 197–198. 3700603
21. Tedesco F. J. (1982). Pseudomembranous colitis: pathogenesis and therapy. Medical Clinics of North America 3, 655–664.
22. Thompson G. M., Gilligan P. H. & Long S. S. (1982). Interrelationships of stool flora and Clostridium difficile in children with cystic fibrosis. Proceedings of the 22nd International Conference on Antimicrobial Agents and Chemotherapy. Abstract 594.
23. Viscidi R., Willey S. & Bartlett J. G. (1981). Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 81, 5–9. 7239125
24. Wilson K. H. & Sheagren J. N. (1983). Antagonism of toxigenic Clostridium difficile by nontoxigenic C. difficile. Journal of Infectious Diseases 4, 733–735.